What Dr. Yang advises about the latest Covid-19 variants:
New Covid Variants Are Circulating. Here’s What to Know.
Dr. Yang is called on by the HuffPost to clarify the importance of a second booster and the role of T cells in protecting against the new COVID variant.
Dr. Yang contributes his expertise to the New York Times about the differences between Omicron and previous Covid-19 strains.
What Are the Symptoms of Omicron?
Dr. Yang's SARS-CoV-2 work is highlighted in the fall 2021 edition of "U" Magazine:
COVID Watchdog - U Magazine - UCLA Health - Los Angeles, CA
Dr. Yang discusses what is known about COVID-19 antibodies and T cell protection immunity against infection with Dr. Mark Hellerstein, a professor in the Department of Nutritional Sciences and Toxicology at UC Berkeley and at the Department of Medicine at UC San Francisco and Dr. Patrick Soon-Shiong, the executive chairman of the Los Angeles Times. Dr. Soon-Shiong is also a surgeon and scientist who has spent his career studying the human immune system in fighting cancer and infectious disease. Last year, Soon-Shiong’s company, ImmunityBio, received permission from the Food and Drug Administration to begin Phase 1 trials of its COVID-19 vaccine candidate.
Will the current crop of COVID vaccines provide lifetime immunity?
Dr. Yang contributes an opinion piece to USA Today about SARS-CoV-2 variants, the efficacy of the vaccines against the variants, and the role of the media addressing the benefits of COVID-19 vaccines.
Forget about the frenzy over COVID-19 variants, viral evolution is normal
Listen to Dr. Yang's interview by Gwyneth Paltrow on the Goop Podcast here:
Gwyneth Paltrow x Otto Yang: COVID-19 Antibodies, Vaccines, and Cutting-Edge Research | Goop
See Dr. Yang’s recent COVID-19 work profiled by the Chan Zuckerberg Initiative here:
Recent Scientific Publications:
Evaluating the T cells that cause rejection of a transplanted hand:
Harnessing blood stem cells for immune gene therapies:
New artificial T cell receptors for treating cytomegalovirus in immunocompromised persons:
Rapidly waning antibodies against SARS-CoV-2 after COVID-19:
Rapidly waning antibodies against SARS-CoV-2 after vaccination:
Antibody levels after prior COVID-19 plus vaccination:
Ability of antibodies to react against SARS-CoV-2 variants after a combination of COVID-9 plus vaccination:
T cell responses against SARS-CoV-2:
Link to a full listing of Dr. Yang’s peer-reviewed scientific publications:
Inquiries about the work of the Yang Immune Innovation Fund may be directed to Dr. Yang at: (310) 791-9491 or [email protected].
Inquiries about donating to the Immune Innovation Fund may be directed to Gretchen McGarry, Executive Director, UCLA Heath Science Development at (310) 794-4746 or [email protected].
Your tax-deductible donation may also be made via this link: http://giving.ucla.edu/immune-innovation.
Thank you for your support of the Yang Immune Innovation Fund